The Traderszone Network

Published in TZ Latest News 7 November, 2017 by The TZ Newswire Staff

Collegium Receives FDA Approval for sNDA for Xtampza® ER

Comparative OxyContin Data and Oral Human Abuse Deterrent Claim Added to Label